Nondisclosure of Financial Interest in Clinical Practice Guideline Development: An Intractable Problem?

English version České info

In a Perspective linked to Stelfox and colleagues, Hilda Bastian discusses the challenges of improving transparency and management of financial conflicts of interest among committees that develop guidelines for medical practice.

Vyšlo v časopise: Nondisclosure of Financial Interest in Clinical Practice Guideline Development: An Intractable Problem?. PLoS Med 13(5): e32767. doi:10.1371/journal.pmed.1002030
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002030

Souhrn

Zdroje

1. Stelfox HT, Campsall P, Colizza K, Straus S. A cross-sectional study of financial relationships between organizations that produce clinical practice guidelines and the biomedical industry. PLOS Med. 2016;13:e1002029. doi: 10.1371/journal.pmed.1002029

2. Taylor R, Giles J. Cash interests taint drug advice. Nature. 2005;437(7062):1070–1071. 16237402

3. Norris SL, Holmer HK, Ogden LA, Selph SS, Fu R. Conflict of interest disclosures for clinical practice guidelines in the National Guideline Clearinghouse. PLOS ONE. 2012;7(11):e47343. doi: 10.1371/journal.pone.0047343 23144816

4. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet. 2000;355(9198):103–106. 10675167

5. Bindslev JBB, Schroll J, Gøtzsche PC, Lundh A. Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study. BMC Med Ethics. 2013;14:19. doi: 10.1186/1472-6939-14-19 23642105

6. Allan GM, Kraut R, Crawshay A, Korownyk C, Vandermeer B, Kolber MR. Contributors to primary care guidelines: what are their professions and how many of them have conflicts of interest? Can Fam Physician. 2015;61:52–58. 25609522

7. National Health and Medical Research Council. A guide to the development, implementation and evaluation of clinical practice guidelines. Canberra: Commonwealth of Australia; 1999. https://www.health.qld.gov.au/cpcre/pdf/nhmrc_clinprgde.pdf

8. Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical practice guidelines we can trust. Washington (DC): National Academies Press; 2011.

9. Schünemann HJ, Al-Ansary LA, Forland F, Kersten S, Komulainen J, Kopp IB, et al., for the Board of Trustees of the Guidelines International Network. Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines. Ann Intern Med. 2015;163:548–553. doi: 10.7326/M14-1885 26436619

10. Graham T, Alderson P, Stokes T. Managing conflicts of interest in the UK National Institute for Health and Care Excellence (NICE) clinical practice guidelines programme: qualitative study. PLOS ONE. 2015;10(3):e0122313. doi: 10.1371/journal.pone.0122313 25811754

11. Moynihan RN, Cooke GPE, Doust JA, Bero L, Hill S, Glasziou PP. Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLOS Med. 2013;10(8):e1001500. doi: 10.1371/journal.pmed.1001500 23966841

12. Bastian H. ‘They would say that, wouldn’t they?’ A reader’s guide to author and sponsor bias in clinical research. J R Soc Med. 2006;99(12):611–614. 17139062